NeuroSense Therapeutics Ltd. (NRSNW) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    NeuroSense Therapeutics L...

    NASDAQ: NRSNW · Real-Time Price · USD
    0.38
    -0.15 (-28.29%)
    At close: Sep 11, 2025, 2:49 PM

    NeuroSense Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 22K 97K 89K n/a
    Gross Profit
    		 -22K -97K -89K -3K
    Operating Income
    		 -9.9M -12.05M -13.55M -5.59M
    Interest Income
    		 2K 178K 91K n/a
    Pretax Income
    		 -10.21M -11.28M -12.34M -4.04M
    Net Income
    		 -10.21M -10.11M -10.49M -2.5M
    Selling & General & Admin
    		 4.18M 4.78M 7.14M 2.5M
    Research & Development
    		 5.7M 7.27M 6.42M 3.08M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 9.88M 12.05M 13.55M 5.59M
    Interest Expense
    		 311K 550K 15K 1.15M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 9.9M 12.05M 13.55M 2.98M
    Income Tax Expense
    		 n/a n/a -1.14M -1.55M
    Shares Outstanding (Basic)
    		 18.6M 13.64M 11.51M 10.86M
    Shares Outstanding (Diluted)
    		 18.6M 13.64M 11.51M 10.86M
    EPS (Basic)
    		 -0.55 -0.83 -0.97 -0.23
    EPS (Diluted)
    		 -0.55 -0.83 -0.97 -0.23
    EBITDA
    		 -9.88M -9.64M -13.38M -2.88M
    EBIT
    		 -9.9M -9.66M -12.32M -2.89M
    Depreciation & Amortization
    		 22K 97K 89K 3K

    Add to Watchlist